Trial intelligence / Profile preview

Safety and humoral immunogenicity of COVID-19 vaccine in patients with solid cancer

TCTR20230510001Completed

Sponsor
Faculty of Medicine, Chiang Mai University
Start
Aug 2021
Countries
1
01

Overview

Trial in coronavirus disease 2019 (COVID-19), sponsored by Faculty of Medicine, Chiang Mai University. Started Aug 2021; status: completed.

02

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on TCTR20230510001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230510001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call